Amylin Acts in the Central Nervous System to Increase Sympathetic Nerve Activity

Overview

Journal Endocrinology

Publisher Oxford University Press

Specialty Endocrinology

Date 2013 May 7

PMID 23645151

Citations 16

Authors

Caroline Fernandes-Santos

Zhongming Zhang

Donald A Morgan

Deng-Fu Guo

Andrew F Russo

Kamal Rahmouni

Affiliations

Soon will be listed here.

Abstract

The pancreatic hormone amylin acts in the central nervous system (CNS) to decrease food intake and body weight. We hypothesized that amylin action in the CNS promotes energy expenditure by increasing the activity of the sympathetic nervous system. In mice, ip administration of amylin significantly increased c-Fos immunoreactivity in hypothalamic and brainstem nuclei. In addition, mice treated with intracerebroventricular (icv) amylin (0.1 and 0.2 nmol) exhibited a dose-related decrease in food intake and body weight, measured 4 and 24 hours after treatment. The icv injection of amylin also increased body temperature in mice. Using direct multifiber sympathetic nerve recording, we found that icv amylin elicited a significant and dose-dependent increase in sympathetic nerve activity (SNA) subserving thermogenic brown adipose tissue (BAT). Of note, icv injection of amylin also evoked a significant and dose-related increase in lumbar and renal SNA. Importantly, icv pretreatment with the amylin receptor antagonist AC187 (20 nmol) abolished the BAT SNA response induced by icv amylin, indicating that the sympathetic effects of amylin are receptor-mediated. Conversely, icv amylin-induced BAT SNA response was enhanced in mice overexpressing the amylin receptor subunit, RAMP1 (receptor-activity modifying protein 1), in the CNS. Our data demonstrate that CNS action of amylin regulates sympathetic nerve outflow to peripheral tissues involved in energy balance and cardiovascular function.

Citing Articles

Mediators of Amylin Action in Metabolic Control.

Boyle C, Zheng Y, Lutz T J Clin Med. 2022; 11(8).

PMID: 35456307 PMC: 9025724. DOI: 10.3390/jcm11082207.

Mouse Microglial Calcitonin Receptor Knockout Impairs Hypothalamic Amylin Neuronal pSTAT3 Signaling but Lacks Major Metabolic Consequences.

Coester B, Lutz T, Le Foll C Metabolites. 2022; 12(1).

PMID: 35050175 PMC: 8780059. DOI: 10.3390/metabo12010051.

The long-acting amylin/calcitonin receptor agonist ZP5461 suppresses food intake and body weight in male rats.

Stein L, McGrath L, Lhamo R, Koch-Laskowski K, Fortin S, Skarbaliene J Am J Physiol Regul Integr Comp Physiol. 2021; 321(2):R250-R259.

PMID: 34259025 PMC: 8409915. DOI: 10.1152/ajpregu.00337.2020.

Impaired Leptin Signalling in Obesity: Is Leptin a New Thermolipokine?.

Genchi V, DOria R, Palma G, Caccioppoli C, Cignarelli A, Natalicchio A Int J Mol Sci. 2021; 22(12).

PMID: 34208585 PMC: 8235268. DOI: 10.3390/ijms22126445.

An inducible model of human amylin overexpression reveals diverse transcriptional changes.

Aldras Y, Singh S, Bode K, Bhowmick D, Jeremic A, OHalloran D Neurosci Lett. 2019; 704:212-219.

PMID: 30974231 PMC: 6594890. DOI: 10.1016/j.neulet.2019.04.016.

References

Kailasam M, Parmer R, Tyrell E, Henry R, OConnor D . Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk. J Hypertens. 2000; 18(11):1611-20. DOI: 10.1097/00004872-200018110-00012. View

Paxinos G, Chai S, Christopoulos G, Huang X, Toga A, Wang H . In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain. J Chem Neuroanat. 2004; 27(4):217-36. DOI: 10.1016/j.jchemneu.2004.03.005. View

Hay D, Christopoulos G, Christopoulos A, Sexton P . Amylin receptors: molecular composition and pharmacology. Biochem Soc Trans. 2004; 32(Pt 5):865-7. DOI: 10.1042/BST0320865. View

Osaka T, Tsukamoto A, Koyama Y, Inoue S . Central and peripheral administration of amylin induces energy expenditure in anesthetized rats. Peptides. 2008; 29(6):1028-35. DOI: 10.1016/j.peptides.2008.02.002. View

Rushing P, Hagan M, Seeley R, Lutz T, Woods S . Amylin: a novel action in the brain to reduce body weight. Endocrinology. 2000; 141(2):850-3. DOI: 10.1210/endo.141.2.7378. View

Arnelo U, Permert J, Adrian T, Larsson J, Westermark P, Reidelberger R . Chronic infusion of islet amyloid polypeptide causes anorexia in rats. Am J Physiol. 1996; 271(6 Pt 2):R1654-9. DOI: 10.1152/ajpregu.1996.271.6.R1654. View

Clark A, Cooper G, Lewis C, Morris J, Willis A, Reid K . Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet. 1987; 2(8553):231-4. DOI: 10.1016/s0140-6736(87)90825-7. View

Malpas S . Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev. 2010; 90(2):513-57. DOI: 10.1152/physrev.00007.2009. View

Bouali S, Wimalawansa S, Jolicoeur F . In vivo central actions of rat amylin. Regul Pept. 1995; 56(2-3):167-74. DOI: 10.1016/0167-0115(95)00009-z. View

10.

Sexton P, Paxinos G, Kenney M, Wookey P, Beaumont K . In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience. 1994; 62(2):553-67. DOI: 10.1016/0306-4522(94)90388-3. View

11.

Leuthauser K, Gujer R, Aldecoa A, McKinney R, Muff R, Fischer J . Receptor-activity-modifying protein 1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition. Biochem J. 2000; 351 Pt 2:347-51. PMC: 1221370. View

12.

Novials A, Rodriguez-Manas L, Chico A, El Assar M, Casas S, Gomis R . Amylin and hypertension: association of an amylin -G132A gene mutation and hypertension in humans and amylin-induced endothelium dysfunction in rats. J Clin Endocrinol Metab. 2007; 92(4):1446-50. DOI: 10.1210/jc.2006-1980. View

13.

Zhang Z, Winborn C, Marquez De Prado B, Russo A . Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci. 2007; 27(10):2693-703. PMC: 6672495. DOI: 10.1523/JNEUROSCI.4542-06.2007. View

14.

Riediger T, Zuend D, Becskei C, Lutz T . The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis. Am J Physiol Regul Integr Comp Physiol. 2003; 286(1):R114-22. DOI: 10.1152/ajpregu.00333.2003. View

15.

Roth J, Maier H, Chen S, Roland B . Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications. Arch Neurol. 2009; 66(3):306-10. DOI: 10.1001/archneurol.2008.581. View

16.

Johnson K, OBrien T, Hayden D, Jordan K, Ghobrial H, Mahoney W . Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Pathol. 1988; 130(1):1-8. PMC: 1880548. View

17.

Lutz T . Amylinergic control of food intake. Physiol Behav. 2006; 89(4):465-71. DOI: 10.1016/j.physbeh.2006.04.001. View

18.

Riediger T, Schmid H, Lutz T, Simon E . Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP. Am J Physiol Regul Integr Comp Physiol. 2001; 281(6):R1833-43. DOI: 10.1152/ajpregu.2001.281.6.R1833. View

19.

Becskei C, Grabler V, Edwards G, Riediger T, Lutz T . Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK. Brain Res. 2007; 1162:76-84. DOI: 10.1016/j.brainres.2007.06.016. View

20.

Hou X, Sun L, Li Z, Mou H, Yu Z, Li H . Associations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese. PLoS One. 2011; 6(9):e24815. PMC: 3174205. DOI: 10.1371/journal.pone.0024815. View